Bangalore, 19 February 2024: FUJIFILM India, a pioneer in diagnostic imaging and information systems, has launched the groundbreaking ALOKA ARIETTA 850 Diagnostic Ultrasound System in India with its first-ever installation at Fortis Hospital in Bengaluru, Karnataka, the state’s leading healthcare services provider. Representing a remarkable advancement in endoscopic technologies, the high-tech ultrasound system aims to enhance diagnostic precision and image clarity for gastrointestinal diseases in the region.
In India, contemporary lifestyles and changing dietary choices are leading to the deteriorating digestive health of the population, adding to the growing prevalence of gastrointestinal (GI) conditions. Addressing this, FUJIFILM India’S ALOKA ARIETTA 850 Endoscopic Ultrasound Machine at Fortis Hospital, Bannerghatta Road, Bengaluru is a significant step in providing world-class diagnostic and therapeutic services for patients against these GI-related diseases, performing targeted treatments such as Pancreatic pseudo cyst drainage (without surgery), targeted delivery of treatment in Pancreatic cancers. Gastrojejunostomy being done non-invasive without surgery by endoscopic ultrasound. Bleeding in liver cirrhosis in stomach can be accurately managed by endoscopic ultrasound guided coiling with this machine. This will also be quite helpful in management of jaundice, EUS guided bile duct drainage and Gallbladder drainage.
Mr. Dheeraj Chaudhri, Head of Endoscopy Division & Endoscopy Systems Division of FUJIFILM India, highlighted, “At FUJIFILM, we are committed to developing cutting-edge medical innovations and technologies to enhance the quality of life across the nation. This momentous installation of ALOKA ARIETTA 850 in Bengaluru exemplifies this effort, ensuring patients in the city receive vital medical support for cancer staging and high-quality diagnostic imaging at the Fortis Hospital. With crystal-clear ultrasound images and integrated processes for both technicians and patients, our goal is to offer superior medical systems in India and positively contribute to the patient care. With our continuous innovation in healthcare technology, we strive to foster a health-conscious India.”
Endoscopic Ultrasound (EUS) is a minimally invasive method for assessing malignancies affecting the digestive (gastrointestinal) tract and neighbouring organs or tissues. With this high degree of accuracy in both diagnostic and therapeutic capacities, it allows doctors to precisely examine organs like the lungs, pancreas, gallbladder, liver, lymph nodes and nearby affected areas. EUS also facilitates the extraction of tissue or fluid samples through a thin needle, eliminating the need for a separate biopsy procedure. Additionally, it improves the staging of cancers with accurate sampling provided by Fine Needle Aspiration (FNA) and Fine Needle Biopsy (FNB). Furthermore, EUS proves valuable in cases of altered anatomy and among cancer patients for various therapeutic procedures.
“We are honoured to welcome the ALOKA ARIETTA 850 system at our facility in Bengaluru as this installation will enhance our existing diagnostic capabilities while ensuring improved and faster results for patients. This cutting-edge endoscopic ultrasound machine signifies technological progress that will revolutionize the healthcare outcomes for the community. It is set to raise the standard of care in gastrointestinal health, facilitating timely and accurate diagnoses crucial in battling cancer and various life-threatening diseases. Previously limited to foreign countries like Japan and the US, we take pride in introducing this technology to India with FUJIFILM India,” said, Dr. Ravindra B S, Director & HOD of Gastroenterology, Fortis Bannerghatta Road, Bengaluru.
FUJIFILM India’s ALOKA ARIETTA 850 stands out from conventional Endoscopic ultrasound machines with a range of superior features. The machine generates exceptional image quality with 7 million digital channels in its B mode. This remarkable system also incorporates HD-THI for deeper penetration, ensuring accurate diagnoses, along with combi-elastography, pure symphonic architecture and CHI-TIC and Inflow Time Mapping for clearer visibility by reducing noise and enhancing the completeness and continuity of tissue boundaries. These advanced features collectively aim to enhance healthcare outcomes and, ultimately, save more lives through early diagnosis of cancers in liver Pancreas and Gastrointestinal organs.
This remarkable launch solidifies FUJIFILM India’s important role in improving healthcare services in India. The company is on a mission to pioneer medical technology and build innovative products to guide humanity toward a healthier and more sustainable way of life.
About FUJIFILM India:
FUJIFILM India Pvt. Ltd. Established in 2007 is a wholly owned subsidiary of FUJIFILM Holdings Corporation, Tokyo. FUJIFILM India is present in three business segments – Healthcare, Materials, and Imaging. With a vast portfolio of technologically advanced products, the company is involved in the business of Healthcare, Endoscopy Systems, Photo Imaging Solutions, Digital Still Camera, Instant Photo System (Instax), Optical Devises, Graphic Communication Solutions, Multifunction Printers, Recording Media & Industrial Product. For more information please visit: https://www.fujifilm.com/in/en
Media Contact
PR and Media Relations - FUJIFILM India Pvt. Ltd. and Teamworks
Pragya Jha
Mobile: +91- 7835000629
Email: Pragya.Jha@fujifilm.com
Name: Shallvi Raj
Mobile: 9835963397
Email: shallvi@groupteamwork.com